 | • レポートコード：MRC2302F0006 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、252ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医薬品 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査レポートでは、2021年に1,069.73百万ドルであった世界の医薬品用ゼラチン市場規模が、2022年に1,135.67百万ドルになり、2027年には1,546.96百万ドルまで、年平均6.34%で成長すると予測しています。本レポートでは、医薬品用ゼラチンの世界市場について調査・分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、ソース別（牛骨、牛皮、豚、家禽、海洋）分析、種類別（タイプA、タイプB）分析、機能別（ゲル化剤、安定剤、増粘剤）分析、用途別（吸収性止血剤、ハードカプセル、ソフトカプセル、錠剤）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況など、以下の構成でお届けします。なお、本書には、Aspire Pharmaceuticals、Baotou Dongbao Bio-Tech Co. Ltd.、Darling Ingredients Inc.、Gelco International、Geliko LLC、Gelita AG、Gelnex Industria E Comercio Ltda、Geltech Co. Ltd.、Henan Boom Gelatin Co. Ltd.、India Gelatine & Chemicals Ltd.、Italgelatine S.p.A.、Juncà Gelatines、Kenney & Ross Limited、Lapi Gelatine S.p.A、Nitta Gelatin Inc.、Norland Products, Inc.、Tessenderlo Group、Trobas Gelatine B.V.、Weishardt、Xiamen Gelken Gelatin Co. Ltd.などの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の医薬品用ゼラチン市場規模：ソース別 - 牛骨ゼラチンの市場規模 - 牛皮ゼラチンの市場規模 - 豚ゼラチンの市場規模 - 家禽ゼラチンの市場規模 - 海洋ゼラチンの市場規模 ・世界の医薬品用ゼラチン市場規模：種類別 - タイプAゼラチンの市場規模 - タイプBゼラチンの市場規模 ・世界の医薬品用ゼラチン市場規模：機能別 - ゲル化剤の市場規模 - 安定剤の市場規模 - 増粘剤の市場規模 ・世界の医薬品用ゼラチン市場規模：用途別 - 吸収性止血剤用ゼラチンの市場規模 - ハードカプセル用ゼラチンの市場規模 - ソフトカプセル用ゼラチンの市場規模 - 錠剤用ゼラチンの市場規模 ・世界の医薬品用ゼラチン市場規模：地域別 - 南北アメリカの医薬品用ゼラチン市場規模 アメリカの医薬品用ゼラチン市場規模 カナダの医薬品用ゼラチン市場規模 ブラジルの医薬品用ゼラチン市場規模 ... - アジア太平洋の医薬品用ゼラチン市場規模 日本の医薬品用ゼラチン市場規模 中国の医薬品用ゼラチン市場規模 インドの医薬品用ゼラチン市場規模 韓国の医薬品用ゼラチン市場規模 台湾の医薬品用ゼラチン市場規模 ... - ヨーロッパ/中東/アフリカの医薬品用ゼラチン市場規模 イギリスの医薬品用ゼラチン市場規模 ドイツの医薬品用ゼラチン市場規模 インドの医薬品用ゼラチン市場規模 フランスの医薬品用ゼラチン市場規模 ロシアの医薬品用ゼラチン市場規模 ... - その他地域の医薬品用ゼラチン市場規模 ・競争状況 ・企業情報 |
The Global Pharmaceutical Gelatin Market size was estimated at USD 1,069.73 million in 2021 and expected to reach USD 1,135.67 million in 2022, and is projected to grow at a CAGR 6.34% to reach USD 1,546.96 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Pharmaceutical Gelatin to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Source, the market was studied across Bovine Bone, Bovine Skin, Marine, Porcine, and Poultry.
Based on Type, the market was studied across Type A and Type B.
Based on Function, the market was studied across Gelling agents & Other Functions, Stabilizing agents, and Thickening agents.
Based on Application, the market was studied across Absorbable Hemostats, Hard Capsules, Soft Capsules, and Tablets.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Pharmaceutical Gelatin market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Pharmaceutical Gelatin Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Pharmaceutical Gelatin Market, including Aspire Pharmaceuticals, Baotou Dongbao Bio-Tech Co. Ltd., Darling Ingredients Inc., Gelco International, Geliko LLC, Gelita AG, Gelnex Industria E Comercio Ltda, Geltech Co. Ltd., Henan Boom Gelatin Co. Ltd., India Gelatine & Chemicals Ltd., Italgelatine S.p.A., Juncà Gelatines, Kenney & Ross Limited, Lapi Gelatine S.p.A, Nitta Gelatin Inc., Norland Products, Inc., Tessenderlo Group, Trobas Gelatine B.V., Weishardt, and Xiamen Gelken Gelatin Co. Ltd..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Pharmaceutical Gelatin Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pharmaceutical Gelatin Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pharmaceutical Gelatin Market?
4. What is the competitive strategic window for opportunities in the Global Pharmaceutical Gelatin Market?
5. What are the technology trends and regulatory frameworks in the Global Pharmaceutical Gelatin Market?
6. What is the market share of the leading vendors in the Global Pharmaceutical Gelatin Market?
7. What modes and strategic moves are considered suitable for entering the Global Pharmaceutical Gelatin Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Large scale use of gelatin in pharma drug dosage
5.1.1.2. Modern capsule filling equipment increasing the multiple filling of diverse systems (beads, granules, small tablets, powders)
5.1.1.3. Increasing adoption of hard gelatin capsules for clinical trials and preliminary drug studies
5.1.2. Restraints
5.1.2.1. Moisture-sensitive concern in some cases and higher price compared to tablets
5.1.2.2. Focus on identifying veggie alternatives for gelatine capsule coating
5.1.3. Opportunities
5.1.3.1. Recent advancements in gelatin nanoparticle in vaccine and drug delivery
5.1.3.2. Rising consciousness about the consumption of nutrition rich food
5.1.4. Challenges
5.1.4.1. Safety and quality concern as increasing incidences of animal-borne diseases
5.2. Cumulative Impact of COVID-19
6. Pharmaceutical Gelatin Market, by Source
6.1. Introduction
6.2. Bovine Bone
6.3. Bovine Skin
6.4. Marine
6.5. Porcine
6.6. Poultry
7. Pharmaceutical Gelatin Market, by Type
7.1. Introduction
7.2. Type A
7.3. Type B
8. Pharmaceutical Gelatin Market, by Function
8.1. Introduction
8.2. Gelling agents & Other Functions
8.3. Stabilizing agents
8.4. Thickening agents
9. Pharmaceutical Gelatin Market, by Application
9.1. Introduction
9.2. Absorbable Hemostats
9.3. Hard Capsules
9.4. Soft Capsules
9.5. Tablets
10. Americas Pharmaceutical Gelatin Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Pharmaceutical Gelatin Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Pharmaceutical Gelatin Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Aspire Pharmaceuticals
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Baotou Dongbao Bio-Tech Co. Ltd.
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. Darling Ingredients Inc.
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Gelco International
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. Geliko LLC
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Gelita AG
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Gelnex Industria E Comercio Ltda
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. Geltech Co. Ltd.
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Henan Boom Gelatin Co. Ltd.
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. India Gelatine & Chemicals Ltd.
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Italgelatine S.p.A.
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Juncà Gelatines
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. Kenney & Ross Limited
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. Lapi Gelatine S.p.A
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. Nitta Gelatin Inc.
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
14.16. Norland Products, Inc.
14.16.1. Business Overview
14.16.2. Key Executives
14.16.3. Product & Services
14.17. Tessenderlo Group
14.17.1. Business Overview
14.17.2. Key Executives
14.17.3. Product & Services
14.18. Trobas Gelatine B.V.
14.18.1. Business Overview
14.18.2. Key Executives
14.18.3. Product & Services
14.19. Weishardt
14.19.1. Business Overview
14.19.2. Key Executives
14.19.3. Product & Services
14.20. Xiamen Gelken Gelatin Co. Ltd.
14.20.1. Business Overview
14.20.2. Key Executives
14.20.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing